Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Edinburgh Plastic Surgery Limited 11/12/2011 Hampson Bahia Consulting Limited 01/07/2011 Ken Stewart Limited 08/04/2009 M S Butterworth Limited 01/04/2010 Prestige Medical Consultancy Limited 01/06/2019 P Addison Medical Limited 01/04/2018 21 November 2025 The principal activity of the LLP during the financial year was that of plastic surgery. OC341979 2025-03-31 OC341979 bus:Director1 2025-03-31 OC341979 bus:Director2 2025-03-31 OC341979 bus:Director3 2025-03-31 OC341979 bus:Director4 2025-03-31 OC341979 bus:Director5 2025-03-31 OC341979 bus:Director6 2025-03-31 OC341979 2024-03-31 OC341979 core:CurrentFinancialInstruments 2025-03-31 OC341979 core:CurrentFinancialInstruments 2024-03-31 OC341979 core:PatentsTrademarksLicencesConcessionsSimilar 2024-03-31 OC341979 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-03-31 OC341979 core:PatentsTrademarksLicencesConcessionsSimilar 2025-03-31 OC341979 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2025-03-31 OC341979 core:FurnitureFittings 2024-03-31 OC341979 core:ComputerEquipment 2024-03-31 OC341979 core:FurnitureFittings 2025-03-31 OC341979 core:ComputerEquipment 2025-03-31 OC341979 2024-04-01 2025-03-31 OC341979 bus:FilletedAccounts 2024-04-01 2025-03-31 OC341979 bus:SmallEntities 2024-04-01 2025-03-31 OC341979 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 OC341979 bus:LimitedLiabilityPartnershipLLP 2024-04-01 2025-03-31 OC341979 bus:Director1 2024-04-01 2025-03-31 OC341979 bus:Director2 2024-04-01 2025-03-31 OC341979 bus:Director3 2024-04-01 2025-03-31 OC341979 bus:Director4 2024-04-01 2025-03-31 OC341979 bus:Director5 2024-04-01 2025-03-31 OC341979 bus:Director6 2024-04-01 2025-03-31 OC341979 core:PatentsTrademarksLicencesConcessionsSimilar core:TopRangeValue 2024-04-01 2025-03-31 OC341979 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill core:TopRangeValue 2024-04-01 2025-03-31 OC341979 core:FurnitureFittings 2024-04-01 2025-03-31 OC341979 core:ComputerEquipment 2024-04-01 2025-03-31 OC341979 2023-04-01 2024-03-31 OC341979 core:PatentsTrademarksLicencesConcessionsSimilar 2024-04-01 2025-03-31 OC341979 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: OC341979 (England and Wales)

EDINBURGH PLASTIC SURGEONS LLP TRADING AS REFINE PLASTIC SURGEONS

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH THE REGISTRAR

EDINBURGH PLASTIC SURGEONS LLP TRADING AS REFINE PLASTIC SURGEONS

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025

Contents

EDINBURGH PLASTIC SURGEONS LLP TRADING AS REFINE PLASTIC SURGEONS

BALANCE SHEET

AS AT 31 MARCH 2025
EDINBURGH PLASTIC SURGEONS LLP TRADING AS REFINE PLASTIC SURGEONS

BALANCE SHEET (continued)

AS AT 31 MARCH 2025
Note 2025 2024
£ £
Fixed assets
Intangible assets 3 1,634 1,664
Tangible assets 4 1,381 1,424
3,015 3,088
Current assets
Debtors 5 85,545 66,365
Cash at bank and in hand 145,648 151,325
231,193 217,690
Creditors: amounts falling due within one year 6 ( 13,909) ( 10,740)
Net current assets 217,284 206,950
Total assets less current liabilities 220,299 210,038
Net assets attributable to members 220,299 210,038
Represented by
Loans and other debts due to members within one year
Other amounts 215,299 210,036
215,299 210,036
Members' other interests
Members' capital classified as equity 5,000 0
Other reserves 0 2
5,000 2
220,299 210,038
Total members' interests
Loans and other debts due to members 215,299 210,036
Members' other interests 5,000 2
220,299 210,038

For the financial year ending 31 March 2025 the LLP was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

Members' responsibilities:

The financial statements of Edinburgh Plastic Surgeons LLP trading as Refine Plastic Surgeons (registered number: OC341979) were approved and authorised for issue by the Board of Directors on 21 November 2025. They were signed on its behalf by:

Edinburgh Plastic Surgery Limited
Designated member
EDINBURGH PLASTIC SURGEONS LLP TRADING AS REFINE PLASTIC SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
EDINBURGH PLASTIC SURGEONS LLP TRADING AS REFINE PLASTIC SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Edinburgh Plastic Surgeons LLP trading as Refine Plastic Surgeons is a limited liability partnership, incorporated in the United Kingdom under the Limited Liability Partnerships Act 2000 and is registered in England and Wales. The address of the LLP's registered office is C/O Johnston Carmichael Birchin Court, 20 Birchin Lane, London, EC3V 9DU, United Kingdom.

The financial statements have been prepared under the historical cost convention and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Limited Liability Partnerships Act 2000 as applicable to companies subject to the small companies regime and the requirements of the Statement of Recommended Practice Accounting by Limited Liability Partnerships issued in December 2021 (SORP 2022). The principal place of business is Refine Plastic Surgeons, Suite 41, Citibase, 1 St Colme Street, Edinburgh, EH3 6AA.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The members have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The members have a reasonable expectation that the LLP has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for plastic surgery services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised as an expense when the LLP is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Defined contribution schemes
The LLP operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Intangible assets

Intangible assets are stated at cost, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost of each asset over its expected useful life as follows:

Trademarks, patents and licences 10 years straight line
Website costs 4 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Fixtures and fittings 25 % reducing balance
Computer equipment 25 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account (if any).

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

Members' participation rights

Members' participation rights are the rights of a member against the LLP that arise under the members' agreement (for example, in respect of amounts subscribed or otherwise contributed, remuneration and profits).

Members’ participation rights in the earnings or assets of the LLP are analysed between those that are, from the LLP's perspective, either a financial liability or equity, in accordance with section 22 of FRS 102. A member’s participation rights including amounts subscribed or otherwise contributed by members, for example members’ capital, are classed as liabilities unless the LLP has an unconditional right to refuse payment to members, in which case they are classified as equity.

The profits are automatically divided as they arise based on the income received by the LLP for work carried out by each member, less a proportionate part of the LLP expenses.

In the event that contract work is undertaken by the LLP and subcontracted to other medical specialists, the profit (or loss) on this work will be divided amongst the Members in proportion to their capital contributions.

All amounts due to members that are classified as liabilities are presented in the Statement of Financial Position within 'Loans and other debts due to members' and are charged to the Profit and Loss Account within 'Members' remuneration charged as an expense'. Amounts due to members that are classified as equity are shown in the Statement of Financial Position within 'Members' other interests'.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the LLP during the year 2 2

3. Intangible assets

Trademarks, patents
and licences
Website costs Total
£ £ £
Cost
At 01 April 2024 2,184 47,520 49,704
Additions 200 0 200
At 31 March 2025 2,384 47,520 49,904
Accumulated amortisation
At 01 April 2024 520 47,520 48,040
Charge for the financial year 230 0 230
At 31 March 2025 750 47,520 48,270
Net book value
At 31 March 2025 1,634 0 1,634
At 31 March 2024 1,664 0 1,664

4. Tangible assets

Fixtures and fittings Computer equipment Total
£ £ £
Cost
At 01 April 2024 1,978 10,457 12,435
Additions 0 516 516
Disposals ( 500) ( 9,659) ( 10,159)
At 31 March 2025 1,478 1,314 2,792
Accumulated depreciation
At 01 April 2024 1,475 9,536 11,011
Charge for the financial year 125 295 420
Disposals ( 491) ( 9,529) ( 10,020)
At 31 March 2025 1,109 302 1,411
Net book value
At 31 March 2025 369 1,012 1,381
At 31 March 2024 503 921 1,424

5. Debtors

2025 2024
£ £
Trade debtors 82,849 64,206
Other debtors 2,696 2,159
85,545 66,365

6. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 1,155 1,476
Other creditors 12,754 9,264
13,909 10,740

7. Financial commitments

Other financial commitments

2025 2024
£ £
Total commitments under non-cancellable operating leases not provided for in the accounts 18,000 0